Counseling about medication-induced birth defects with clinical decision support in primary care

Journal of Women's Health

Volumn 22, Issue 10, 2013, Pages 817-824

  Schwarz, Eleanor Bimla ^a,b,c   Parisi, Sara M ^a   Handler, Steven M ^a,c   Koren, Gideon ^d   Shevchik, Grant ^c   Fischer, Gary S ^a,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; TERATOGENIC AGENT;

ADULT; ARTICLE; BIRTH CONTROL; BIRTH DEFECT; CONTRACEPTION; CONTRACEPTIVE BEHAVIOR; DECISION SUPPORT SYSTEM; FEMALE; GENERAL PRACTITIONER; HEALTH CARE SURVEY; HUMAN; MAJOR CLINICAL STUDY; PATIENT COUNSELING; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK FACTOR;

ABNORMALITIES, DRUG-INDUCED; ADOLESCENT; ADULT; COUNSELING; DECISION SUPPORT SYSTEMS, CLINICAL; DRUG PRESCRIPTIONS; FAMILY PLANNING SERVICES; FEMALE; HEALTH CARE SURVEYS; HUMANS; LOGISTIC MODELS; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, PRIMARY CARE; PREGNANCY; PRIMARY HEALTH CARE; TERATOGENS; YOUNG ADULT;

EID: 84885034529     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2013.4262     Document Type: Article

References (20)

1. Schwarz EB, Maselli J, Norton M, Gonzales R. Prescription of teratogenic medications in United States ambulatory practices. Am J Med 2005;11:1240-1249
2. Schwarz EB, Postlethwaite DA, Hung YY, Armstrong MA. Documentation of contraception and pregnancy when prescribing potentially teratogenic medications for reproductive-Age women. Ann Intern Med 2007; 6:370-376
3. Finer LB, Henshaw SK. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health 2006;2:90-96
4. Santucci AK, Gold MA, Akers AY, Borrero S, Schwarz EB. Women's perspectives on counseling about risks for medication-induced birth defects. Birth Defects Res A Clin Mol Teratol 2010;1:64-69
5. Nordeng H, Koren G, Einarson A. Pregnant women's beliefs about medications-A study among 866 Norwegian women. Ann Pharmacother 2010; 9:1478-1484
6. D'Angelo D, Williams L, Morrow B, et al. Preconception and interconception health status of women who recently gave birth to a live-born infant-Pregnancy Risk Assessment Monitoring System (PRAMS), United States, 26 reporting areas, 2004. MMWR Surveill Summ 2007;10:1-35
7. Andrade SE, Gurwitz JH, Davis RL, et al. Prescription drug use in pregnancy. Am J Obstet Gynecol 2004; 2:398-407
8. Lee E, Maneno MK, Smith L, et al. National patterns of medication use during pregnancy. Pharmacoepidemiol Drug Saf 2006;8:537545
9. Felix RJ, Jones KL, Johnson KA, McCloskey CA, Chambers CD, Organization of Teratology Information Services Collaborative Research G. Postmarketing surveillance for drug safety in pregnancy: The Organization of Teratology Information Services project. Birth Defects Res A Clin Mol Teratol 2004;12:944-947
10. Schwarz EB, Parisi SM, Handler SM, et al. Clinical decision support to promote safe prescribing to women of repro-ductive age: A cluster-randomized trial. J Gen Intern Med 2012;7:831-838
11. Schwarz EB, Mattocks K, Brandt C, et al. Counseling of female veterans about risks of medication-induced birth defects. J Gen Intern Med 2013;28 Suppl 2:598-603
12. Isaacs JN, Creinin MD. Miscommunication between healthcare providers and patients may result in unplanned pregnancies small star, filled. Contraception 2003;5:373-376
13. Lee JK, Parisi SM, Akers AY, Borrero S, Schwarz EB. The impact of contraceptive counseling in primary care on contraceptive use. J Gen Intern Med 2011;7:731-766
14. Upson K, Reed SD, Prager SW, Schiff MA. Factors associated with contraceptive nonuse among U.S. women ages 35-44 years at risk of unwanted pregnancy. Contraception 2010;5:427-434
15. Huber LR, Ersek JL. Contraceptive use among sexually active university students. J Womens Health (Larchmt). 2009;7:1063-1070
16. Curtis KM, Jamieson DJ, Peterson HB, Marchbanks PA. Adaptation of the World Health Organization's medical eligibility criteria for contraceptive use for use in the United States. Contraception 2010;1:3-9
17. Parisi SM, Zikovich S, Chuang CH, Sobota M, Nothnagle M, Schwarz EB. Primary care physicians' perceptions of rates of unintended pregnancy. Contraception 2012;1:48-54
18. Eisenberg DL, Secura GM, Madden TE, Allsworth JE, Zhao Q, Peipert JF. Knowledge of contraceptive effectiveness. Am J Obstet Gynecol 2012;6:479 e1-9
19. Raebel MA, Carroll NM, Kelleher JA, Chester EA, Berga S, Magid DJ. Randomized trial to improve prescribing safety during pregnancy. J Am Med Inform Assoc 2007;4:440-450
20. Davison SL, Bell RJ, LaChina M, Holden SL, Davis SR. Sexual function in well women: Stratification by sexual satisfaction, hormone use, and menopause status. J Sex Med 2008;5:1214-1222